Shire
Biotechnology company
Shire plc was a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019. Wikipedia
Headquarters: Lexington, MA
CEO: Flemming Ørnskov (Apr 30, 2013–)
Revenue: 15.16 billion USD
Number of employees: 23,044 (2018)
Parent organization: Takeda Pharmaceutical Company
Recent FIXX News
- Homology Medicines Declares Distribution to Common Stockholders • GlobeNewswire Inc. • 03/18/2024 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2024 11:37:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:32:56 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/21/2024 09:04:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/15/2024 05:15:36 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/13/2024 03:11:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:54:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:49:06 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/03/2024 09:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:26:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:15 PM
- Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 01/03/2024 09:08:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:05:19 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:19:25 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:16:27 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:13:55 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:46:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:16:09 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • GlobeNewswire Inc. • 11/16/2023 12:05:00 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • PR Newswire (US) • 11/16/2023 12:05:00 PM
- Homology Medicines Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/14/2023 09:33:57 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM